| A review on possible therapeutic targets to contain obesity: The role of phytochemicals M Balaji, MS Ganjayi, GENH Kumar, BN Parim, R Mopuri, S Dasari Obesity research & clinical practice 10 (4), 363-380, 2016 | 122 | 2016 |
| Therapeutics to tackle Omicron outbreak VP Chavda, EN Hanuma Kumar Ghali, MM Yallapu, V Apostolopoulos Immunotherapy 14 (11), 833-838, 2022 | 32 | 2022 |
| Antiobesity activity of Bauhinia purpurea extract: Effect on hormones and lipid profile in high calorie diet induced obese rats TK Padmaja, PB Naidu, GENH Kumar, S Ganapathy, M Balaji Advances in Bioscience and Biotechnology 5 (11), 861-873, 2014 | 23 | 2014 |
| Inulin-based formulations as an emerging therapeutic strategy for cancer: a comprehensive review ENHK Ghali, SC Chauhan, MM Yallapu International journal of biological macromolecules 259, 129216, 2024 | 22 | 2024 |
| Protein subunit vaccines: Promising frontiers against COVID-19 VP Chavda, ENHK Ghali, PC Balar, SC Chauhan, N Tiwari, S Shukla, ... Journal of Controlled Release 366, 761-782, 2024 | 19 | 2024 |
| Ethanolic fraction of Terminalia tomentosa attenuates biochemical and physiological derangements in diet induced obese rat model by regulating key lipid metabolizing enzymes … B Meriga, PB Naidu, G Muniswamy, GENH Kumar, RR Naik, S Pothani Pharmacognosy Magazine 13 (51), 385, 2017 | 12 | 2017 |
| Pterocarpus santalinus L. extract mitigates gamma radiation-inflicted derangements in BALB/c mice by Nrf2 upregulation GENH Kumar, SS Kumar, M Balaji, DK Maurya, M Kesavulu Biomedicine & Pharmacotherapy 141, 111801, 2021 | 11 | 2021 |
| Radioprotective Properties of Pterocarpus santalinus Chloroform Extract in Murine Splenic Lymphocytes and Possible Mechanism ENHK Ghali, DK Maurya, B Meriga Cancer biotherapy & radiopharmaceuticals 33 (10), 427-437, 2018 | 10 | 2018 |
| Enhanced human exposure to radiations, role of phytochemicals as potential radio-protectants: a review GE Hanumakumar, M Balaji, RS Karunakaran Int J Pharm Sci Res 9 (7), 2656-2668, 2018 | 8 | 2018 |
| Role of phytoconstituents and their mechanism in attenuation of radiation effects: an update GENH Kumar, DK Maurya, B Viswanath, M Balaji Recent developments in applied microbiology and biochemistry, 55-76, 2021 | 3 | 2021 |
| One-step simultaneous liquid phase exfoliation-induced chirality in graphene and their chirality-mediated microRNA delivery ENHK Ghali, N Chauhan, R Tiwari, M Cabrera, SC Chauhan, MM Yallapu Materials Advances 4 (23), 6199-6212, 2023 | 2 | 2023 |
| Novel nanoformulation of piperlongumine attenuates pancreatic tumor desmoplasia and modulates tumor immune responses VK Kashyap, R Mandes, N Chauhan, D Zubieta, M Sikander, ENHK Ghali, ... | | 2025 |
| Reconstitution of miRNA-205 in Docetaxel Resistant Prostate Cancer Cells: A Nanotherapeutic Approach N Chauhan, ENHK Ghali, R Tiwari, I Enriquez, R Baru, SC Chauhan, ... | | 2025 |
| Fabrication of docetaxel loaded PCL/PLGA electrospun nanofibers for lung cancer therapy R Tiwari, F Pranav, EN Hanuma Kumar Ghali, S Chauhan, M Yallapu, ... | | 2025 |
| Antifungal Drugs as Emerging Candidates for Prostate Cancer Treatment ENHK Ghali, R Tiwari, RJ Chang, SY Jung, VK Kashyap, A Dhasmana, ... | | 2025 |
| Insights into the radioprotective efficacy of Pterocarpus santalinus L. aqueous extract ENHK Ghali, SK Sandopu, DK Maurya, B Meriga Fitoterapia 176, 105986, 2024 | | 2024 |
| Paclitaxel nanoformulation attenuates pancreatic tumor desmoplasia and alter tumor immune responses VK Kashyap, GP Darkwah, N Chauhan, M Sikander, EN Ghali, M Kolli, ... Cancer Research 84 (6_Supplement), 486-486, 2024 | | 2024 |
| Engineered Inhalation nanoparticle formulation for lung cancer R Tiwari, EN Ghali, N Chauhan, V Kashyap, SC Chauhan, MM Yallapu Cancer Research 84 (6_Supplement), 2070-2070, 2024 | | 2024 |
| Development of cross-linked tannic acid-based nanoparticle for lung cancer treatment R Tiwari, VK Kashyap, ENHK Ghali, SC Chauhan, MM Yallapu | | 2024 |
| Breakthrough medicines during the COVID-19 pandemic era ENHK Ghali, V Dhevan, S K Narmala, M Jaggi, S C Chauhan, ... Future drug discovery 4 (1), FDD69, 2022 | | 2022 |